The Brikama Magistrate Court has convicted Mr. Dawda Sey for operating a Drug Premise without a license, contrary to Section 60 of the Medicines and Related Product Act, 2014. Mr. Sey appeared before Magistrate I.O. Njie, where he maintained his guilty plea after the narration of facts by the Prosecutor. Inspector S.I.W. Dibba, representing the […]
Man Convicted for Operating Unlicensed Pharmacy Read More »
Mr. Alagie Jabbie has been remanded to Mile II Central Prison after appearing before Magistrate I. Dibba of the Bundung Magistrates Court on 01 September 2025. He was charged under Section 59(1)(e) of the Medicines and Related Products Act, 2014, for operating an unauthorised medicines premise in Sanchaba. Mr. Jabbie pleaded guilty to the charge
Man Remanded to Mile II Prison for Operating Unauthorised Drug Premise Read More »
The Bundung Magistrates Court fined Mr. Alagie Touray the sum of D500,000, in default of which he will serve five years in prison, for operating an unauthorized drug premises in contravention of Section 60 of the Medicines and Related Products Act, 2014. The case was presided over by Magistrate M. Mendy and Mr. Touray, a
Man Fined D500,000 for Operating Unauthorized Drug Premises Read More »
The Medicines Control Agency (MCA) had the honour of receiving Her Excellency Ms. Imma Roca i Cortés, EU Ambassador to The Gambia, on a courtesy visit on the 28th of August 2025, as part of her familiarization tour to various institutions. The visit also served as a key stakeholder engagement for MCA. In attendance were
A man appeared before the Brikama Magistrates Court charged under Section 59(1)(e) of the Medicines and Related Products Act, 2014. Representing the Inspector General of Police, Inspector K. Kanyi and Sergeant J. Pereira brought the matter before Magistrate I.O. Njie on Wednesday, 27th August 2025. The accused, Mr. Demba Jarju, pleaded not guilty to the
IGP Mentions a Case to Court on Unauthorised Medicines Storage Read More »
Charged under section 60 of the Medicines and Related Products Act, 2014, Mr. Dawda Sey, the accused, pleaded guilty to the charge after being mentioned before Magistrate I.O. Njie of the Brikama Magistrate Court on Wednesday, 27th August, 2025. The case was later adjourned to Tuesday, 2nd September, 2025 for prosecution to narrate the facts
Man Pleaded Guilty to Storing Medicines in an unauthorised Premise Read More »
In a move highlighting MCA’s commitment to safeguarding public health, the Bundung Magistrates Court, on the 25th August 2025, convicted Matarr Jagne for the unauthorized storage of medicines. Presiding over the case, Magistrate I. Dibba sentenced Jagne to pay a fine of D100,000, in default of paying the fine, the convict will serve four years
Bundung Magistrates Court Convicts Man for Unauthorized Storage of Medicines Read More »
The Medicines Control Agency (MCA) informs the public that it has secured the conviction of three individuals for storing medicines in an unauthorized premises. Mr. Stephen Kofi Annan, Mr. Kojo Sey, and Mr. Abdoulie Jobe, all first-time offenders, were each fined D50,000 by Magistrate Isatou Jallow of the Brusubi Magistrate Court on 21st August 2025.
3 Convicted for Unauthorised Storage of Medicines Read More »
A team from the Medicines Control Agency (MCA), The Gambia, is currently on a study visit to the Senegalese Pharmaceutical Regulatory Agency (ARP) from 28 July to 1 August 2025. This visit forms part of ongoing efforts to strengthen collaboration between the two National Regulatory Authorities (NRAs) on their Regulatory Functions including the fight against
MCA and ARP Strengthen Ties Through Study Visit and MoU Signing Read More »
The Paul-Ehrlich-Institut (PEI) of the Federal Ministry of Health Germany recently concluded a five-day training session from 07-11 July 2025 for Staff of The Directorate of Clinical Trials and Pharmacovigilance (DCTPV), Medicines Control Agency (MCA), The Gambia. The training aimed at improving the skills and capacity of Staff of the DCTPV in the regulation of
Capacity Building Training on Clinical Trials and Pharmacovigilance Read More »
